WASHINGTON: AdvaMed, the trade group for the medical technology industry, has upped Wanda Moebius to EVP of public affairs.
Moebius, who previously served as AdvaMed’s SVP of public affairs, was promoted on April 1. She is not replacing anyone in the EVP position and the company has yet to decide if it is going to hire a replacement for her previously role, according to Moebius.
She oversees six staffers at the company and reports to JC Scott, AdvaMed's senior EVP of government affairs.
Moebius will continue to lead the overall strategic direction for AdvaMed’s comms program and member engagement activities, as well as provide senior counsel to policy colleagues.
Additionally, she will focus her efforts on AdvaMed’s Life Changing Innovation campaign, a consumer-facing effort to educate the public about the value of medical technology and diagnostics.
"I am really excited to work with this industry and have an opportunity to explain to the media and the public the tremendous advancements and innovation in this space, from genetic sequencing to the artificial heart to state of the art exoskeletons," Moebius said.
She added that the enormous change in the sector "is resulting in a lot of value for patients and the overall health system."
Moebius joined AdvaMed as a VP in 2007. She replaced Gary Karr when she was promoted to her most recent role in October 2013. Karr went on to serve as executive director of national business comms at Aetna, and started a new role earlier this year as group director at WCG, a W2O Group company.
Earlier in her career, Moebius served in senior director roles at PhRMA, Dittus Communications, and Hill & Knowlton, according to her LinkedIn profile.